Evidence map›Paper›PMID 35759181›Full record

ReviewInternational journal of hematology2022

The role of specialized cell cycles during erythroid lineage development: insights from single-cell RNA sequencing.

Merav Socolovsky

Open access · bronzeAbstract readReview
In one paragraph

Review in International journal of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. diffGEK: differential gene expression kinetics.Bioinformatics (Oxford, England) · 2025
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Merav SocolovskyDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA. merav.socolovsky@umassmed.edu.ORCID http://orcid.org/0000-0001-6747-7960
University of Massachusetts Chan Medical School · US

Funding

The DNA damage response of fast-cycling erythroblastsR01DK130498 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SCULLY, RALPH, SOCOLOVSKY, MERAV · 2021 to 2025
$2.9M
Novel Growth Factor Regulators of Early ErythropoieisisR01HL141402 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KLEIN, ALLON MOSHE, SOCOLOVSKY, MERAV · 2018 to 2021
$2.6M
Specialized cell cycles in early erythropoiesisR01DK120639 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SOCOLOVSKY, MERAV · 2019 to 2023
$2.2M
NHLBI NIH HHS R01 HL141402NIDDK NIH HHS R01 DK120639NIDDK NIH HHS R01 DK130498
6 · The paper itself

Abstract

Early erythroid progenitors known as CFU-e undergo multiple self-renewal cell cycles. The CFU-e developmental stage ends with the onset of erythroid terminal differentiation (ETD). The transition from CFU-e to ETD is a critical cell fate decision that determines erythropoietic rate. Here we review recent insights into the regulation of this transition, garnered from flow cytometric and single-cell RNA sequencing studies. We find that the CFU-e/ETD transition is a rapid S phase-dependent transcriptional switch. It takes place during an S phase that is much shorter than in preceding or subsequent cycles, as a result of globally faster replication forks. Furthermore, it is preceded by cycles in which G1 becomes gradually shorter. These dramatic cell cycle and S phase remodeling events are directly linked to regulation of the CFU-e/ETD switch. Moreover, regulators of erythropoietic rate exert their effects by modulating cell cycle duration and S phase speed. Glucocorticoids increase erythropoietic rate by inducing the CDK inhibitor p57

Indexed as

Erythroid Precursor CellsErythropoietinCell CycleCell DifferentiationCyclin-Dependent Kinase Inhibitor p57ErythropoiesisHumansSequence Analysis, RNACyclin-Dependent Kinase Inhibitor p57ErythropoietinCDK inhibitorsCell cycleErythropoiesisErythropoietic stress responseGlucocorticoidsReplication forks

Identifiers

PMID35759181
PMCPMC12302956
OpenAlexW4283660468

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.